Internal target volume defined by contrast-enhanced 4D-CT scan in unresectable pancreatic tumour: Evaluation and reproducibility

Radiotherapy and Oncology

Volumn 97, Issue 3, 2010, Pages 525-529

  Cattaneo, Giovanni Mauro ^a   Passoni, Paolo ^a   Sangalli, Giulia ^a   Slim, Najla ^a   Longobardi, Barbara ^a   Mancosu, Pietro ^a   Bettinardi, Valentino ^a   Muzio, Nadia Di ^a   Calandrino, Riccardo ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Internal target volume; Intra observer variability; Pancreatic ductal adenocarcinoma; Radiotherapy; Respiratory gated 4D CT

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; FEMALE; FOUR DIMENSIONAL COMPUTED TOMOGRAPHY; HUMAN; MALE; PANCREAS ADENOCARCINOMA; PANCREAS TUMOR; PRIORITY JOURNAL; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, PANCREATIC DUCTAL; CONTRAST MEDIA; FEMALE; FOUR-DIMENSIONAL COMPUTED TOMOGRAPHY; HUMANS; MALE; MIDDLE AGED; OBSERVER VARIATION; PANCREATIC NEOPLASMS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; REPRODUCIBILITY OF RESULTS; RESPIRATION; TRIIODOBENZOIC ACIDS; TUMOR BURDEN;

EID: 78651520168     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2010.08.007     Document Type: Article

References (23)

1. E. Ben-Josef, A.F. Shields, U. Vaishampayan, V. Vaitkevicius, B.F. El-Rayes, and P. McDermott Intensity modulated radiotherapy (IMRT) and concurrent capecitabine for pancreatic cancer Int J Radiat Oncol Biol Phys 59 2004 454 459
2. B. Bussels, L. Goethals, M. Feron, D. Bielen, S. Dymarkowski, and P. Suetens Respiration-induced movement of the upper abdominal organs: a pitfall for the three-dimensional conformal radiation treatment of pancreatic cancer Radiother Oncol 68 2003 69 74
3. A. Dickler, and R.A. Abrams Radiochemotherapy in the management of pancreatic cancer-part II: use in adjuvant and locally unresectable settings Semin Radiat Oncol 15 2005 235 244
4. J.G. Fletcher, M.J. Wiersema, M.A. Farrell, J.L. Fidler, L.J. Burgart, and T. Koyama Pancreatic malignancy: value of arterial, pancreatic, and hepatic phase imaging with multi-detector row CT Radiology 229 2003 81 90
5. D.P. Gierga, G.T. Chen, J.H. Kung, M. Betke, J. Lombardi, and C.G. Willett Quantification of respiration-induced abdominal tumour motion and its impact of IMRT dose distribution Int J Radiat Oncol Biol Phys 58 2004 1584 1595
6. S.D. Goldstein, E.C. Ford, M. Duhon, T. McNutt, J. Wong, and J.M. Herman Use of respiratory-correlated 4D-CT to determine acceptable treatment margins for locally advanced pancreatic adenocarcinoma Int J Radiat Oncol Biol Phys 76 2010 597 602
7. K.M. Horton, and L.H. Fishman Adenocarcinoma of the pancreas: CT imaging Radiol Clin North Am 40 2002 1263 1272
8. P. Jayachandran, A.Y. Minn, J. Van Dam, J.A. Norton, A.C. King, and D.T. Chang Interfractional uncertainty in the treatment of pancreatic cancer with radiation Int J Radiat Oncol Biol Phys 76 2010 603 607
9. K.M. Langen, and D.T.L. Jones Organ motion and its management Int J Radiat Oncol Biol Phys 50 2001 265 278
10. P. Mancosu, V. Bettinardi, P. Passoni, S. Gusmini, S. Cappio, and M.C. Gilardi Contrast enhanced 4D-CT imaging for target volume definition in pancreatic ductal adenocarcinoma Radiat Oncol 87 2008 339 342
11. G.P. Mazzara, R.P. Velthuizen, J.L. Pearlman, H.M. Greenberg, and H.W. Wagner Brain tumour target volume determination for radiation treatment planning trough automated MRI segmentation Int J Radiat Oncol Biol Phys 59 2004 300 312
12. N.J. McNulty, I.R. Francis, J.F. Platt, R.H. Cohan, M. Korobkin, and A. Gebremariam Multi-detector row helical CT of the pancreas: effect of contrast-enhanced multiphasic imaging on enhancement of the pancreas, peripancreatic vasculature, and pancreatic adenocarcinoma Radiology 220 2001 97 102
13. M.T. Milano, S.J. Chmura, M.C. Garofalo, C. Rash, J.C. Roeske, and P.P. Connell Intensity-modulated radiotherapy in treatment of pancreatic and bile duct malignancies: toxicity and clinical outcome Int J Radiat Oncol Biol Phys 59 2004 445 453
14. S. Mori, R. Hara, T. Yanagi, G.C. Sharp, M. Kumagai, and H. Asakura Four-dimensional measurement of intrafractional respiratory motion of pancreatic tumours using a 256 multi-slice CT scanner Radiother Oncol 92 2009 231 237
15. J.D. Murphy, S. Adusumilli, K.A. Griffith, M.E. Ray, M.M. Zalupski, T.S. Lawrence, and E. Ben-Josef Full dose gemcitabine and concurrent radiotherapy for unresectable pancreatic cancer Int J Radiation Oncology Biol Phys 68 2007 801 808
16. T. Pan, T.Y. Lee, E. Rietzel, and G.T. Chen 4D-CT imaging of a volume influenced by respiratory motion on multi-slice CT Med Phys 31 2004 333 340
17. R.W. Prokesch, W. Schima, L.C. Chow, and R.B. Jeffrey Multidetector CT of pancreatic adenocarcinoma: diagnostic advances and therapeutic relevance Radiology 224 2002 764 768
18. E. Rietzel, G.T. Chen, N.C. Choi, and C.G. Willet Four-dimensional image-based treatment planning target volume segmentation and dose calculation in the presence of respiratory motion Int J Radiat Oncol Biol Phys 61 2005 535 550
19. W.Y. Song, B. Chiu, G.S. Bauman, M. Lock, G. Rodrigues, and R. Ash Prostate contouring uncertainty in megavoltage computed tomography images acquired with a helical tomotherapy unit during image-guided radiation therapy Int J Radiat Oncol Biol Phys 65 2006 595 607
20. E. Van Cutsem, R. Aerts, K. Haustermans, B. Topal, W. Van Steenbergen, and C. Verslype Systemic treatment of pancreatic cancer Eur J Gastroenterol Hepatol 12 2004 265 274
21. M. van Herk Errors and margins in radiotherapy Semin Radiat Oncol 14 2004 52 64
22. M. Xi, M.Z. Liu, X.W. Deng, L. Zhang, X.Y. Huang, and H. Liu Defining internal target volume (ITV) for hepatocellular carcinoma using four-dimensional CT Radiother Oncol 8 2007 272 278
23. H. Yamazaky, K. Nishiyama, E. Tanaka, K. Koiwai, N. Shikama, and Y. Ito Dummy run for a phase II multi-institute trial of chemoradiotherapy for unresectable pancreatic cancer: inter-observer variance in contour delineation Anticancer Res 27 2007 2965 2971